Nissan Chemical Corporation is developing new manufacturing systems of large quantities of cell spheroids for regenerative medicines and drug discoveries and are now seeking potential collaborators for development of new applications of this system.
We are seeking startups that want to design products and develop business using electric de-bonding technology.
Braskem is a $15B global plastic manufacturer in Brazil. They are looking to manufacture Plastic/composite ties that will outlast wood, ideally using recycled material. They currently have this capability but are looking for product advantage/benefits around: rail/wheel interaction; ballast’s maintenance consumption; Life Cycle cost of the tie; Environment requisitions; and pavement’s levels design.
FM Global is a mutually-owned, commercial, property-risk insurer based out of Johnston, Rhode Island, United States. We are a non-traditional insurer, focused on engineering analysis to determine premium and risk. FM Global believes that majority of losses are preventable. Historically, FM Global has focused on sprinklers and other conventional loss prevention technologies.
IMA SpA makes machines for packaging coffee, tea, cosmetics, pharmaceuticals. The company sales are about USD 700M. They have operations around the world. Customers include Unilever, Novartis, Bigelow. They seek robotics startups for repetitive tasks.
Sompo Japan Insurance seeks Startups in AgTech, Energy, and IoT
A $17B/year global leader in automotive technologies, Faurecia is anticipating all the challenges of a changing industry. With the help of strategic partnerships with companies, start-ups and academia within an open innovation ecosystem, Faurecia technologies address two key aspects of mobility: the Cockpit of the Future for a safer, more comfortable, and more intuitive experience in the cockpit of the future, and Sustainable Mobility for cleaner and more environmentally-friendly transportation around the world. Owns more than 300 assembly lines in the US.
The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.